The legal marijuana industry is changing lives, and a revolutionary new technology is changing how companies here can deliver top-notch products to their customer. It’s truly transformative.
And that’s excellent news for marijuana stocks…
Marijuana growers are no different from growers of any other agricultural product. Despite the lingering stigma and legal aspects, marijuana growers want to deliver the best possible product in many categories. They want to satisfy the industry’s desire for robust plants that grow quickly and produce a high yield.
And they want to satisfy consumers’ preferences for variations in taste, smell, precision dosing, and desired effects. The better they meet those needs, the more they sell, and the higher price they command.
Unfortunately, the U.S. Drug Enforcement Agency’s (DEA) classification of the plant as a schedule 1 drug means the federal government deems marijuana as having no accepted medical use. Currently, marijuana is classified similarly to meth and heroin.
Urgent: Top Three California Pot Stocks to Watch for the Biggest Gains – Learn How to Cash In Here
That, in turn, means the well-funded research needed to usher in the next round of cannabis-based wonder drugs is not as robust as it needs to be. But even so, there is still research being performed.
The real problem is that there is no database, central or otherwise, that keeps track of different strains of marijuana plants and their different traits. Food crop geneticists can simply enter a few factors and out comes reams of data telling them how they can breed for whatever characteristic they need.
But that could soon change for marijuana growers…
And for investors, this will be a massive catalyst for the best marijuana stocks in 2018…
Genetic Sequencing Is a Massive Catalyst for Marijuana Stocks in 2018
The good news is that machines now exist to sequence the marijuana genome.
For example, Illumina Inc.’s (Nasdaq: ILMN) new machines help cannabis laboratories identify marijuana’s 800 million base pairs and 10 chromosomes. That information will help pot breeders discover more markers for specific traits like potency, aroma, and, most importantly, medicinal properties.
Of course, there is only progress when there is a profit motive. And as more jurisdictions bring legal weed online, including full legalization in Canada and Massachusetts this summer, the market’s desire for ever refined and differentiated products will only grow.
For companies that turn weed into medicine and other products, the ability to order plants with specific characteristics makes their jobs both easier and more effective. After all, knowing exactly what compounds their plants contain and exactly what processing is needed to create their products will clearly benefit the company’s bottom line – and the user experience.
What’s even better is that the prices for these sequencing machines are coming down. Currently, it costs about $1,000 for a series of genetic tests. Compare that to the $1 million it took a few years ago to sequence the human genome.
Money Morning Director of Technology & Venture Capital Research Michael Robinson has had his eye on genomic sequencing in the marijuana industry for quite a while. In fact, he recommended subscribers get in on Illumina stock on Nov. 17, and it gained 19% since then. Compare that to the S&P 500, with its 5.15% gain.
But since sequencing is still in its infancy – as is legal marijuana – the potential for Illumina and many other companies here is huge. Robinson sees triple-digit gains ahead for Illumina in just a few short years. Indeed, we still do not know the full capabilities of the next generation of drugs and therapies that cannabis can provide. Genetic sequencing is the key to unlocking that potential.
That’s why Robinson is bringing readers the following opportunity in the marijuana market…
These Three Pot Stocks Could Turn a Small Stake into Millions
California is bracing for a tsunami-sized wave of wealth – and if you play your cards right, you could make more money from the marijuana markets than you’ve ever seen in your life.
You see, thanks to The Golden State’s complete cannabis legalization, $20.2 BILLION is expected to flood this industry, delivering massive upward momentum to tiny cannabis startups currently trading for pennies apiece.
But as soon as the money starts flowing into these small companies, and their share prices go from $1, to $5, to $20 or more… you may never see a chance like this again.
Your first step on the road to marijuana millions starts right here.
About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.To get full access to all Money Morning content, click here.
Disclaimer: © 2018 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.